177 related articles for article (PubMed ID: 9250482)
1. Age-related changes in susceptibility of mice to low-virulent mouse hepatitis virus (MHV-2-CC) infection.
Suzuki H; Kiatipattanasakul W; Kajikawa S; Tsutsui S; Nakayama H; Goto N; Doi K
Exp Anim; 1997 Jul; 46(3):211-8. PubMed ID: 9250482
[TBL] [Abstract][Full Text] [Related]
2. Resistance of naive mice to murine hepatitis virus strain 3 requires development of a Th1, but not a Th2, response, whereas pre-existing antibody partially protects against primary infection.
Pope M; Chung SW; Mosmann T; Leibowitz JL; Gorczynski RM; Levy GA
J Immunol; 1996 May; 156(9):3342-9. PubMed ID: 8617959
[TBL] [Abstract][Full Text] [Related]
3. A Th1 cell line (3E9.1) from resistant A/J mice inhibits induction of macrophage procoagulant activity in vitro and protects against MHV-3 mortality in vivo.
Chung S; Gorczynski R; Cruz B; Fingerote R; Skamene E; Perlman S; Leibowitz J; Fung L; Flowers M; Levy G
Immunology; 1994 Nov; 83(3):353-61. PubMed ID: 7835959
[TBL] [Abstract][Full Text] [Related]
4. Role of spleen macrophages in innate and acquired immune responses against mouse hepatitis virus strain A59.
Wijburg OL; Heemskerk MH; Boog CJ; Van Rooijen N
Immunology; 1997 Oct; 92(2):252-8. PubMed ID: 9415034
[TBL] [Abstract][Full Text] [Related]
5. Expression of B and T lymphocyte attenuator (BTLA) in macrophages contributes to the fulminant hepatitis caused by murine hepatitis virus strain-3.
Yang C; Chen Y; Guo G; Li H; Cao D; Xu H; Guo S; Fei L; Yan W; Ning Q; Zheng L; Wu Y
Gut; 2013 Aug; 62(8):1204-13. PubMed ID: 22637698
[TBL] [Abstract][Full Text] [Related]
6. Clara Cell 10 kDa Protein Alleviates Murine Hepatitis Virus Strain 3-Induced Fulminant Hepatitis by Inhibiting Fibrinogen-Like Protein 2 Expression.
Yu H; Liu Y; Wang H; Wan X; Huang J; Yan W; Xi D; Luo X; Shen G; Ning Q
Front Immunol; 2018; 9():2935. PubMed ID: 30619295
[No Abstract] [Full Text] [Related]
7. Resistance of naive mice to murine hepatitis virus strain 3 requires development of a Th1, but not a Th2, response, whereas pre-existing antibody partially protects against primary infection.
Liu MF; Ning Q; Pope M; Mosmann T; Leibowitz J; Ding JW; Fung LS; Rotstein O; Gorczynski R; Levy GA
Adv Exp Med Biol; 1998; 440():415-23. PubMed ID: 9782309
[TBL] [Abstract][Full Text] [Related]
8. Role of virus-specific CD4+ cytotoxic T cells in recovery from mouse hepatitis virus infection.
Wijburg OL; Heemskerk MH; Sanders A; Boog CJ; Van Rooijen N
Immunology; 1996 Jan; 87(1):34-41. PubMed ID: 8666433
[TBL] [Abstract][Full Text] [Related]
9. Pattern of disease after murine hepatitis virus strain 3 infection correlates with macrophage activation and not viral replication.
Pope M; Rotstein O; Cole E; Sinclair S; Parr R; Cruz B; Fingerote R; Chung S; Gorczynski R; Fung L
J Virol; 1995 Sep; 69(9):5252-60. PubMed ID: 7636967
[TBL] [Abstract][Full Text] [Related]
10. Factors involved in the age-dependent resistance of mice infected with low-virulence mouse hepatitis virus.
Taguchi F; Yamada A; Fujiwara K
Arch Virol; 1979; 62(4):333-40. PubMed ID: 94538
[TBL] [Abstract][Full Text] [Related]
11. Acquired immunity of A/J mice to mouse hepatitis virus 3 infection: dependence on interferon-gamma synthesis and macrophage sensitivity to interferon-gamma.
Lucchiari MA; Martin JP; Modolell M; Pereira CA
J Gen Virol; 1991 Jun; 72 ( Pt 6)():1317-22. PubMed ID: 1646275
[TBL] [Abstract][Full Text] [Related]
12. Characterization of accessory cell function during acute infection of BALB/cByJ mice with mouse hepatitis virus (MHV), strain JHM.
de Souza MS; Smith AL
Lab Anim Sci; 1991 Apr; 41(2):112-8. PubMed ID: 1658437
[TBL] [Abstract][Full Text] [Related]
13. Role of macrophage procoagulant activity in mouse hepatitis virus (MHV) infection: studies using T cell MHV-3 clones and monoclonal antibody 3D4.3.
Chung S; Li C; Fung LS; Crow A; Gorczynski R; Cole E; Perlman S; Leibowitz J; Levy G
Adv Exp Med Biol; 1993; 342():377-84. PubMed ID: 8209757
[No Abstract] [Full Text] [Related]
14. The novel CD4+CD25+ regulatory T cell effector molecule fibrinogen-like protein 2 contributes to the outcome of murine fulminant viral hepatitis.
Shalev I; Wong KM; Foerster K; Zhu Y; Chan C; Maknojia A; Zhang J; Ma XZ; Yang XC; Gao JF; Liu H; Selzner N; Clark DA; Adeyi O; Phillips MJ; Gorczynski RR; Grant D; McGilvray I; Levy G
Hepatology; 2009 Feb; 49(2):387-97. PubMed ID: 19085958
[TBL] [Abstract][Full Text] [Related]
15. Resistance to murine hepatitis virus strain 3 is dependent on production of nitric oxide.
Pope M; Marsden PA; Cole E; Sloan S; Fung LS; Ning Q; Ding JW; Leibowitz JL; Phillips MJ; Levy GA
J Virol; 1998 Sep; 72(9):7084-90. PubMed ID: 9696801
[TBL] [Abstract][Full Text] [Related]
16. Virus specificity of the antiviral state induced by IFN gamma correlates with resistance to MHV 3 infection.
Mello IG; Vassão RC; Pereira CA
Arch Virol; 1993; 132(3-4):281-9. PubMed ID: 7691047
[TBL] [Abstract][Full Text] [Related]
17. Duration of mouse hepatitis virus infection: studies in immunocompetent and chemically immunosuppressed mice.
Barthold SW; Smith AL
Lab Anim Sci; 1990 Mar; 40(2):133-7. PubMed ID: 2157090
[TBL] [Abstract][Full Text] [Related]
18. T cell epitope specificity and pathogenesis of mouse hepatitis virus-1-induced disease in susceptible and resistant hosts.
Khanolkar A; Fulton RB; Epping LL; Pham NL; Tifrea D; Varga SM; Harty JT
J Immunol; 2010 Jul; 185(2):1132-41. PubMed ID: 20554960
[TBL] [Abstract][Full Text] [Related]
19. Pathogenesis of enterotropic mouse hepatitis virus in immunocompetent and immunodeficient mice.
Compton SR; Ball-Goodrich LJ; Johnson LK; Johnson EA; Paturzo FX; Macy JD
Comp Med; 2004 Dec; 54(6):681-9. PubMed ID: 15679267
[TBL] [Abstract][Full Text] [Related]
20. Purification of the 110-kilodalton glycoprotein receptor for mouse hepatitis virus (MHV)-A59 from mouse liver and identification of a nonfunctional, homologous protein in MHV-resistant SJL/J mice.
Williams RK; Jiang GS; Snyder SW; Frana MF; Holmes KV
J Virol; 1990 Aug; 64(8):3817-23. PubMed ID: 2164599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
